Copolymer 1: an off-beat drug development story.
Scheindlin
Stanley
S
D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate